MECHLORETHAMINE HYDROCHLORIDE

MECHLORETHAMINE HYDROCHLORIDE was reported 2247 times

MECHLORETHAMINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE HYPERTROPHY 6 0.4286
1 MYCOSIS FUNGOIDES REFRACTORY 2 0.3333
2 CUTANEOUS T-CELL LYMPHOMA RECURRENT 19 0.3016
3 MYCOSIS FUNGOIDES RECURRENT 8 0.2759
4 APPLICATION SITE JOINT SWELLING 1 0.2000
5 REGIONAL CHEMOTHERAPY 1 0.1667
6 APPLICATION SITE FISSURE 12 0.1333
7 ADMINISTRATION SITE EROSION 1 0.1250
8 CUTANEOUS T-CELL LYMPHOMA STAGE III 2 0.0870
9 APPLICATION SITE WOUND 13 0.0788
10 VOLVULUS REPAIR 1 0.0769
11 APPLICATION SITE CELLULITIS 5 0.0746
12 LARYNGOCELE 1 0.0667
13 LYMPHOMA OPERATION 1 0.0667
14 APPLICATION SITE MACULE 1 0.0667
15 APPLICATION SITE ATROPHY 2 0.0606
16 CUTANEOUS T-CELL LYMPHOMA STAGE IV 2 0.0556
17 CUTANEOUS T-CELL LYMPHOMA STAGE II 1 0.0455
18 MYCOSIS FUNGOIDES STAGE II 1 0.0435
19 APPLICATION SITE PLAQUE 1 0.0435
20 MYCOSIS FUNGOIDES 34 0.0413
21 APPLICATION SITE DISCHARGE 45 0.0390
22 CUTANEOUS T-CELL LYMPHOMA 47 0.0373
23 APPLICATION SITE ALOPECIA 2 0.0364
24 MYCOSIS FUNGOIDES STAGE IV 1 0.0345
25 FOLLICULAR DISORDER 1 0.0278
26 APPLICATION SITE EROSION 33 0.0256
27 APPLICATION SITE INFECTION 13 0.0255
28 APPLICATION SITE DISCOLOURATION 102 0.0251
29 THIRD DEGREE CHEMICAL BURN OF SKIN 1 0.0238
30 OROPHARYNGEAL SURGERY 1 0.0222
31 APPLICATION SITE NODULE 3 0.0219
32 PAPILLOMA EXCISION 1 0.0217
33 INCISION SITE ULCER 1 0.0208
34 APPLICATION SITE HYPERAESTHESIA 2 0.0202
35 APPLICATION SITE INFLAMMATION 27 0.0195
36 THORACOSTOMY 1 0.0192
37 SKIN LESION REMOVAL 1 0.0185
38 MISCARRIAGE OF PARTNER 1 0.0182
39 APPLICATION SITE PAPULES 18 0.0170
40 BIOPSY SKIN 3 0.0169
41 APPLICATION SITE ULCER 12 0.0169
42 SECOND DEGREE CHEMICAL BURN OF SKIN 1 0.0167
43 EXPOSURE VIA MUCOSA 1 0.0167
44 APPLICATION SITE SCAB 33 0.0153
45 CSF SHUNT OPERATION 1 0.0139
46 EXPOSURE VIA INHALATION 3 0.0139
47 SYSTEMIC BACTERIAL INFECTION 1 0.0133
48 APPLICATION SITE DRYNESS 40 0.0118
49 APPLICATION SITE COLDNESS 1 0.0118
50 APPLICATION SITE WARMTH 15 0.0118
51 APPLICATION SITE ECZEMA 1 0.0115
52 INTRACARDIAC PRESSURE INCREASED 1 0.0114
53 APPLICATION SITE VESICLES 73 0.0112
54 POST PROCEDURAL ERYTHEMA 1 0.0112
55 ADMINISTRATION SITE INFLAMMATION 1 0.0111
56 BENIGN TUMOUR EXCISION 1 0.0110
57 APPLICATION SITE EXFOLIATION 45 0.0109
58 SKIN DISCHARGE 4 0.0105
59 PERICARDIAL EXCISION 1 0.0104
60 ATYPICAL MYCOBACTERIUM TEST POSITIVE 1 0.0103
61 BIOPSY LYMPH GLAND 1 0.0102
62 APPLICATION SITE PAIN 218 0.0099
63 APPLICATION SITE PRURITUS 224 0.0099
64 APPLICATION SITE NECROSIS 1 0.0097
65 APPLICATION SITE LACERATION 4 0.0097
66 APPLICATION SITE SWELLING 48 0.0096
67 MICROGRAPHIC SKIN SURGERY 2 0.0093
68 APPLICATION SITE OEDEMA 3 0.0093
69 APPLICATION SITE HAEMORRHAGE 24 0.0088
70 SKIN SQUAMOUS CELL CARCINOMA RECURRENT 1 0.0088
71 ANEURYSM REPAIR 1 0.0088
72 APPLICATION SITE ERYTHEMA 220 0.0084
73 APPLICATION SITE ACNE 4 0.0082
74 BRACHIOCEPHALIC VEIN THROMBOSIS 1 0.0081
75 APPLICATION SITE IRRITATION 101 0.0081
76 MEDICAL DEVICE SITE ERYTHEMA 1 0.0078
77 SUPERFICIAL VEIN PROMINENCE 2 0.0078
78 SKIN EROSION 25 0.0078
79 BODY SURFACE AREA INCREASED 1 0.0078
80 SKIN NEOPLASM EXCISION 6 0.0077
81 ECZEMA WEEPING 1 0.0076
82 APPLICATION SITE MASS 2 0.0073
83 BLADDER NEOPLASM SURGERY 1 0.0072
84 NEOPLASM SKIN 11 0.0071
85 APPLICATION SITE ODOUR 1 0.0069
86 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 4 0.0068
87 BLISTER RUPTURE 5 0.0067
88 LIMB FRACTURE 1 0.0067
89 APPLICATION SITE HYPERSENSITIVITY 8 0.0066
90 MUCOCUTANEOUS RASH 1 0.0065
91 SKIN WEEPING 23 0.0064
92 APPLICATION SITE DERMATITIS 6 0.0064
93 RECTAL LESION 1 0.0064
94 MEDICAL DEVICE SITE JOINT INFECTION 1 0.0064
95 ALLOGENIC STEM CELL TRANSPLANTATION 1 0.0063
96 CANCER SURGERY 6 0.0063
97 SKIN TEXTURE ABNORMAL 6 0.0063
98 CYSTOSCOPY 1 0.0063
99 APPLICATION SITE BRUISE 6 0.0062
100 OESOPHAGEAL DILATION PROCEDURE 1 0.0060
101 APPLICATION SITE INDURATION 1 0.0059
102 APPLICATION SITE PUSTULES 2 0.0055
103 EAR OPERATION 2 0.0054
104 RED CELL DISTRIBUTION WIDTH ABNORMAL 1 0.0053
105 NORMOCHROMIC ANAEMIA 1 0.0050
106 ADULT FAILURE TO THRIVE 1 0.0047
107 APPLICATION SITE BURN 23 0.0047
108 CHOLELITHOTOMY 1 0.0046
109 SKIN HYPERPIGMENTATION 38 0.0044
110 T-CELL LYMPHOMA 5 0.0044
111 WOUND SECRETION 17 0.0043
112 MALABSORPTION FROM ADMINISTRATION SITE 1 0.0043
113 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 1 0.0042
114 EXPOSURE VIA DIRECT CONTACT 4 0.0042
115 CANCER FATIGUE 1 0.0042
116 EAR NEOPLASM MALIGNANT 1 0.0042
117 PULMONARY CONTUSION 1 0.0040
118 APPLICATION SITE URTICARIA 9 0.0040
119 DRAIN PLACEMENT 1 0.0039
120 GLAUCOMA SURGERY 1 0.0039
121 WOUND DRAINAGE 3 0.0038
122 CONJUNCTIVITIS VIRAL 1 0.0038
123 SKIN BACTERIAL INFECTION 3 0.0037
124 INTESTINAL CYST 1 0.0037
125 APPLICATION SITE REACTION 25 0.0036
126 SKIN WOUND 6 0.0035
127 ADMINISTRATION SITE ERYTHEMA 1 0.0035
128 APPLICATION SITE RASH 47 0.0034
129 BACTERIAL TEST 1 0.0034
130 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 2 0.0033
131 SKIN DISCOLOURATION 147 0.0032
132 BED REST 1 0.0032
133 RADIOTHERAPY 6 0.0031
134 MITRAL VALVE REPAIR 1 0.0031
135 BLOOD VISCOSITY DECREASED 1 0.0030
136 SCAB 34 0.0030
137 MASS EXCISION 1 0.0029
138 TENOPLASTY 1 0.0029
139 URETERAL STENT INSERTION 1 0.0029
140 FIBROUS HISTIOCYTOMA 1 0.0028
141 PREGNANCY OF PARTNER 2 0.0028
142 NO THERAPEUTIC RESPONSE 34 0.0028
143 HEART VALVE STENOSIS 1 0.0028
144 DYSPLASTIC NAEVUS 1 0.0028
145 INTENTIONAL DOSE OMISSION 79 0.0028
146 MILIA 1 0.0028
147 BREAST RECONSTRUCTION 1 0.0027
148 AZOOSPERMIA 1 0.0026
149 BLADDER OPERATION 3 0.0026
150 METASTATIC LYMPHOMA 1 0.0026
151 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 1 0.0026
152 STICKY SKIN 1 0.0025
153 TUMOUR EXCISION 2 0.0025
154 VASCULAR OPERATION 1 0.0025
155 LYMPHOCYTIC LEUKAEMIA 1 0.0025
156 SKIN IRRITATION 112 0.0024
157 URETERAL DISORDER 1 0.0024
158 SPLENIC RUPTURE 4 0.0024
159 APPLICATION SITE SCAR 3 0.0024
160 OTITIS MEDIA CHRONIC 1 0.0024
161 ABDOMINAL CAVITY DRAINAGE 1 0.0024
162 GENITAL LESION 1 0.0024
163 MILIARIA 4 0.0023
164 ABSCESS DRAINAGE 2 0.0023
165 FACIAL NERVE DISORDER 1 0.0023
166 SKIN LESION 62 0.0023
167 APPLICATION SITE DISCOMFORT 4 0.0022
168 ALLERGY TO PLANTS 1 0.0022
169 SYMPTOM RECURRENCE 13 0.0022
170 CARDIAC PACEMAKER REPLACEMENT 1 0.0022
171 SKIN GRAFT 2 0.0022
172 BIOPSY BONE MARROW 1 0.0021
173 SKIN HYPERTROPHY 6 0.0021
174 MECHANICAL URTICARIA 1 0.0021
175 GRAFT VERSUS HOST DISEASE IN LUNG 1 0.0021
176 TELANGIECTASIA 2 0.0021
177 SKIN SWELLING 18 0.0021
178 DERMATITIS INFECTED 1 0.0020
179 TINEA CRURIS 1 0.0020
180 CHEMICAL BURN OF SKIN 5 0.0020
181 SKIN SENSITISATION 2 0.0019
182 DERMATITIS CONTACT 22 0.0019
183 BLISTER 107 0.0019
184 SKIN ABRASION 9 0.0019
185 DERMATITIS 39 0.0019
186 FRACTURE PAIN 1 0.0019
187 EPHELIDES 1 0.0019
188 SKIN REACTION 26 0.0018
189 PAPULE 13 0.0018
190 INTERTRIGO 1 0.0018
191 PILOERECTION 2 0.0018
192 POST PROCEDURAL SWELLING 2 0.0018
193 PAIN OF SKIN 49 0.0018
194 OESOPHAGEAL FOOD IMPACTION 1 0.0018
195 ADRENAL HAEMORRHAGE 1 0.0018
196 BODY TINEA 1 0.0018
197 TUMOUR RUPTURE 1 0.0018
198 MEDICAL DEVICE SITE PAIN 1 0.0018
199 NAIL BED BLEEDING 1 0.0018
200 OPHTHALMIC HERPES SIMPLEX 1 0.0017
201 SKIN ATROPHY 10 0.0017
202 IRREGULAR BREATHING 1 0.0017
203 INCISION SITE PAIN 2 0.0017
204 EYE BURNS 1 0.0017
205 SKIN HYPOPIGMENTATION 3 0.0017
206 AMBLYOPIA 1 0.0017
207 RECTOCELE 1 0.0017
208 PROSTATIC OPERATION 2 0.0017
209 THERAPY NON-RESPONDER 74 0.0016
210 THYROXINE DECREASED 1 0.0016
211 RENAL SURGERY 1 0.0015
212 ACROCHORDON 2 0.0015
213 SKIN TIGHTNESS 7 0.0015
214 HEAD AND NECK CANCER 1 0.0015
215 FEELING OF RELAXATION 1 0.0015
216 SCROTAL OEDEMA 1 0.0014
217 NONINFECTIVE GINGIVITIS 2 0.0014
218 FINGER AMPUTATION 1 0.0014
219 ANKLE OPERATION 2 0.0014
220 HEART VALVE REPLACEMENT 2 0.0014
221 ASPIRATION PLEURAL CAVITY 1 0.0013
222 SKIN FISSURES 25 0.0013
223 BLISTER INFECTED 1 0.0013
224 EYELID EXFOLIATION 1 0.0013
225 SKIN BURNING SENSATION 89 0.0012
226 SKIN ULCER 32 0.0012
227 SKIN FRAGILITY 3 0.0012
228 SCIATIC NERVE INJURY 1 0.0012
229 SKIN WARM 7 0.0012
230 VULVOVAGINAL ERYTHEMA 1 0.0012
231 LUNG OPERATION 1 0.0012
232 PATERNAL EXPOSURE DURING PREGNANCY 1 0.0012
233 CYSTOCELE 1 0.0012
234 SKIN DISCOMFORT 3 0.0011
235 UTERINE DILATION AND CURETTAGE 1 0.0011
236 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
237 BIOPSY 1 0.0011
238 SKIN HAEMORRHAGE 16 0.0011
239 PHARYNGEAL HYPOAESTHESIA 1 0.0011
240 PYELOCALIECTASIS 1 0.0010
241 BLOOD URINE 1 0.0010
242 ERYTHEMA 213 0.0010
243 EPIDERMAL NECROSIS 1 0.0010
244 LYMPHADENECTOMY 1 0.0010
245 SKIN DISORDER 34 0.0010
246 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
247 SKIN OEDEMA 1 0.0010
248 FUNGAL SKIN INFECTION 4 0.0010
249 EAR HAEMORRHAGE 2 0.0010
250 PIGMENTATION DISORDER 6 0.0010
251 SKIN INDURATION 2 0.0010
252 THERAPY PARTIAL RESPONDER 15 0.0010
253 SENSITIVE SKIN 7 0.0009
254 RADIATION INJURY 1 0.0009
255 PURULENT DISCHARGE 4 0.0009
256 PRODUCT CONTAINER ISSUE 8 0.0009
257 UTERINE PROLAPSE 1 0.0009
258 ACARODERMATITIS 1 0.0009
259 ACINETOBACTER INFECTION 1 0.0009
260 WOUND 25 0.0009
261 RASH PAPULAR 20 0.0009
262 BENIGN NEOPLASM 1 0.0009
263 DRUG EFFECT VARIABLE 1 0.0009
264 WOUND COMPLICATION 3 0.0009
265 CHEMICAL BURN 1 0.0009
266 CHRONIC SPONTANEOUS URTICARIA 1 0.0009
267 RADIATION SKIN INJURY 1 0.0009
268 ORAL SURGERY 2 0.0009
269 THERMAL BURN 6 0.0008
270 PUSTULE 2 0.0008
271 PRURITUS 322 0.0008
272 DISEASE PROGRESSION 99 0.0008
273 COLON OPERATION 1 0.0008
274 SKIN PLAQUE 7 0.0008
275 SKIN EXFOLIATION 70 0.0008
276 WRONG DOSE 2 0.0008
277 FOOT OPERATION 4 0.0008
278 TREATMENT NONCOMPLIANCE 44 0.0008
279 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
280 CHEMOTHERAPY 3 0.0008
281 LIP DISCOLOURATION 1 0.0008
282 TESTICULAR SWELLING 1 0.0008
283 THERAPEUTIC PRODUCT INEFFECTIVE 3 0.0008
284 APPLICATION SITE PARAESTHESIA 1 0.0008
285 HERPES OPHTHALMIC 1 0.0008
286 SKIN PAPILLOMA 3 0.0007
287 LIP BLISTER 2 0.0007
288 SKIN DEPIGMENTATION 1 0.0007
289 NONSPECIFIC REACTION 4 0.0007
290 DRY SKIN 97 0.0007
291 RED BLOOD CELL COUNT INCREASED 2 0.0007
292 SECOND PRIMARY MALIGNANCY 6 0.0007
293 THERAPEUTIC PROCEDURE 1 0.0007
294 SKIN INFECTION 8 0.0007
295 NECK MASS 2 0.0007
296 SHOULDER OPERATION 3 0.0007
297 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
298 MELANOCYTIC NAEVUS 3 0.0007
299 NEPHRECTOMY 1 0.0007
300 AXILLARY PAIN 1 0.0007
301 EXPIRED PRODUCT ADMINISTERED 22 0.0007
302 EYE OPERATION 3 0.0007
303 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 11 0.0006
304 CONDITION AGGRAVATED 194 0.0006
305 MEDICAL DEVICE IMPLANTATION 1 0.0006
306 INHIBITORY DRUG INTERACTION 1 0.0006
307 TINEA PEDIS 1 0.0006
308 TOTAL LUNG CAPACITY DECREASED 1 0.0006
309 OCCUPATIONAL EXPOSURE TO PRODUCT 4 0.0006
310 MALIGNANT NEOPLASM PROGRESSION 63 0.0006
311 KNEE OPERATION 6 0.0006
312 RESUSCITATION 1 0.0006
313 SKIN MASS 4 0.0006
314 TYMPANIC MEMBRANE PERFORATION 1 0.0006
315 LEUKAEMIA RECURRENT 1 0.0006
316 SPLEEN DISORDER 1 0.0006
317 B-CELL LYMPHOMA 2 0.0006
318 BLADDER NEOPLASM 1 0.0006
319 CARDIAC OPERATION 5 0.0006
320 CERVICAL SPINAL STENOSIS 1 0.0006
321 SKIN NECROSIS 3 0.0006
322 SPONDYLOLISTHESIS 1 0.0006
323 RASH MACULAR 20 0.0006
324 GASTROINTESTINAL OEDEMA 1 0.0006
325 JUGULAR VEIN THROMBOSIS 1 0.0006
326 WOUND HAEMORRHAGE 2 0.0005
327 CATHETER PLACEMENT 1 0.0005
328 SQUAMOUS CELL CARCINOMA 5 0.0005
329 INFECTED SKIN ULCER 1 0.0005
330 LIP DISORDER 1 0.0005
331 BONE MARROW TRANSPLANT 1 0.0005
332 RASH PRURITIC 28 0.0005
333 SKIN CANCER 11 0.0005
334 PNEUMONIA FUNGAL 2 0.0005
335 CATARACT OPERATION 3 0.0005
336 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
337 DEVICE RELATED SEPSIS 1 0.0005
338 LIPIDS INCREASED 1 0.0005
339 RENAL MASS 1 0.0005
340 THYROID FUNCTION TEST ABNORMAL 2 0.0005
341 TENDERNESS 5 0.0005
342 ATRIAL TACHYCARDIA 1 0.0005
343 SLEEP DEFICIT 1 0.0005
344 EAR SWELLING 1 0.0005
345 LYMPHOCYTOSIS 1 0.0005
346 METASTATIC NEOPLASM 2 0.0005
347 INCOHERENT 3 0.0005
348 OESOPHAGEAL VARICES HAEMORRHAGE 1 0.0005
349 BURNING SENSATION 32 0.0005
350 COLONOSCOPY 1 0.0005
351 SPINAL COLUMN INJURY 1 0.0004
352 INFECTIOUS MONONUCLEOSIS 1 0.0004
353 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
354 ORAL PRURITUS 1 0.0004
355 LYMPHOEDEMA 3 0.0004
356 NECK SURGERY 1 0.0004
357 CONTRAST MEDIA REACTION 1 0.0004
358 VOLVULUS 1 0.0004
359 LIMB OPERATION 2 0.0004
360 LYMPHADENITIS 1 0.0004
361 SLOW SPEECH 1 0.0004
362 SPINAL OPERATION 5 0.0004
363 CARTILAGE INJURY 1 0.0004
364 NEOPLASM MALIGNANT 27 0.0004
365 DERMATITIS ALLERGIC 5 0.0004
366 URINARY TRACT INFECTION BACTERIAL 1 0.0004
367 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
368 EXCORIATION 1 0.0004
369 ENDODONTIC PROCEDURE 1 0.0004
370 TOE AMPUTATION 2 0.0004
371 APPENDICITIS PERFORATED 1 0.0004
372 DIABETIC COMPLICATION 1 0.0004
373 HIP ARTHROPLASTY 6 0.0004
374 CANCER PAIN 1 0.0004
375 FOOD ALLERGY 3 0.0004
376 ANKLE FRACTURE 6 0.0004
377 FAILURE TO THRIVE 2 0.0004
378 RETINAL DISORDER 1 0.0004
379 COMPARTMENT SYNDROME 1 0.0004
380 EXFOLIATIVE RASH 1 0.0004
381 FURUNCLE 3 0.0004
382 BRUXISM 2 0.0004
383 HYDROCEPHALUS 2 0.0004
384 WOUND INFECTION 4 0.0004
385 MACULE 1 0.0004
386 THERAPEUTIC RESPONSE DELAYED 1 0.0004
387 ANAL HAEMORRHAGE 1 0.0004
388 PRODUCT COMPLAINT 9 0.0004
389 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
390 SEASONAL ALLERGY 5 0.0004
391 LIP PAIN 1 0.0003
392 EXPOSURE VIA SKIN CONTACT 9 0.0003
393 PRODUCT ADMINISTRATION ERROR 7 0.0003
394 EYELID MARGIN CRUSTING 1 0.0003
395 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
396 HAEMOTHORAX 1 0.0003
397 PULMONARY MASS 5 0.0003
398 PROTHROMBIN TIME PROLONGED 2 0.0003
399 ATYPICAL PNEUMONIA 1 0.0003
400 BLOOD CULTURE POSITIVE 1 0.0003
401 HYPERCAPNIA 1 0.0003
402 LOCALISED INFECTION 8 0.0003
403 MYELOFIBROSIS 1 0.0003
404 DYSCHEZIA 1 0.0003
405 DIABETIC FOOT 1 0.0003
406 BLOOD BLISTER 1 0.0003
407 EXPOSURE TO TOXIC AGENT 1 0.0003
408 CARDIAC FLUTTER 2 0.0003
409 POSTURE ABNORMAL 1 0.0003
410 BACTERIAL SEPSIS 1 0.0003
411 HYPOVENTILATION 1 0.0003
412 LYMPHOCYTE COUNT INCREASED 1 0.0003
413 RASH 132 0.0003
414 SKIN INJURY 1 0.0003
415 UPPER LIMB FRACTURE 6 0.0003
416 ANXIETY DISORDER 1 0.0003
417 MALIGNANT MELANOMA 4 0.0003
418 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
419 NEOPLASM RECURRENCE 1 0.0003
420 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
421 HEPATIC CYST 1 0.0003
422 RASH ERYTHEMATOUS 14 0.0003
423 ONYCHOCLASIS 2 0.0003
424 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
425 SCRATCH 3 0.0003
426 LOGORRHOEA 1 0.0003
427 APPENDICECTOMY 1 0.0003
428 CELLULITIS 14 0.0003
429 PHARYNGITIS STREPTOCOCCAL 3 0.0003
430 MYELODYSPLASTIC SYNDROME 4 0.0003
431 DERMATITIS BULLOUS 2 0.0003
432 PULMONARY THROMBOSIS 3 0.0003
433 RASH PUSTULAR 2 0.0003
434 CAROTID ARTERY OCCLUSION 1 0.0003
435 THERAPY CESSATION 14 0.0003
436 VENTRICULAR FIBRILLATION 3 0.0003
437 NEURODERMATITIS 1 0.0003
438 SUNBURN 2 0.0003
439 LOSS OF CONTROL OF LEGS 1 0.0003
440 LYMPHOMA 4 0.0003
441 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
442 ORAL INFECTION 1 0.0003
443 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
444 NAIL DISCOLOURATION 1 0.0003
445 SKIN ODOUR ABNORMAL 1 0.0003
446 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
447 WRIST FRACTURE 3 0.0003
448 GALLBLADDER OPERATION 1 0.0002
449 POST PROCEDURAL INFECTION 2 0.0002
450 RECURRENT CANCER 1 0.0002
451 ANAPHYLACTOID REACTION 1 0.0002
452 SPINAL STENOSIS 1 0.0002
453 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
454 SURGERY 14 0.0002
455 KNEE ARTHROPLASTY 5 0.0002
456 MUSCLE FATIGUE 1 0.0002
457 ANURIA 2 0.0002
458 PRURITUS GENERALISED 5 0.0002
459 HYSTERECTOMY 2 0.0002
460 CHAPPED LIPS 1 0.0002
461 BLOOD CALCIUM INCREASED 2 0.0002
462 LIGAMENT RUPTURE 1 0.0002
463 LYMPHADENOPATHY 8 0.0002
464 BLOOD CREATINE INCREASED 1 0.0002
465 RHINITIS ALLERGIC 1 0.0002
466 BRAIN NEOPLASM MALIGNANT 1 0.0002
467 URINARY TRACT DISORDER 1 0.0002
468 VASCULAR DEVICE INFECTION 1 0.0002
469 DISEASE COMPLICATION 1 0.0002
470 EAR DISORDER 1 0.0002
471 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
472 PRODUCT DISTRIBUTION ISSUE 2 0.0002
473 BACTERIAL INFECTION 4 0.0002
474 TIBIA FRACTURE 1 0.0002
475 STAPHYLOCOCCAL INFECTION 7 0.0002
476 LEUKAEMIA 2 0.0002
477 SARCOIDOSIS 1 0.0002
478 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
479 ECZEMA 11 0.0002
480 EYE INFLAMMATION 2 0.0002
481 HYPOVOLAEMIC SHOCK 1 0.0002
482 SUBCUTANEOUS ABSCESS 1 0.0002
483 RASH VESICULAR 1 0.0002
484 DRUG DOSE OMISSION 34 0.0002
485 OFF LABEL USE 179 0.0002
486 PHARYNGEAL SWELLING 2 0.0002
487 THERAPY CHANGE 2 0.0002
488 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
489 SINUS DISORDER 4 0.0002
490 ANEURYSM 1 0.0002
491 HYPERNATRAEMIA 1 0.0002
492 VEIN DISORDER 1 0.0002
493 DERMATITIS EXFOLIATIVE 1 0.0002
494 ERYSIPELAS 1 0.0002
495 BLOOD COUNT ABNORMAL 3 0.0002
496 DYSLIPIDAEMIA 1 0.0002
497 SLUGGISHNESS 2 0.0002
498 DRUG ADMINISTRATION ERROR 6 0.0002
499 EAR DISCOMFORT 2 0.0002
500 THYROID DISORDER 3 0.0002
501 RASH GENERALISED 5 0.0002
502 VENTRICULAR EXTRASYSTOLES 2 0.0002
503 PRODUCT USE COMPLAINT 3 0.0002
504 COMPRESSION FRACTURE 1 0.0002
505 NIGHT SWEATS 6 0.0002
506 OVERWEIGHT 1 0.0002
507 INTESTINAL RESECTION 1 0.0002
508 INTENTIONAL PRODUCT MISUSE 16 0.0002
509 THERAPY INTERRUPTED 13 0.0002
510 GASTROINTESTINAL PAIN 2 0.0002
511 DEAFNESS UNILATERAL 1 0.0002
512 PROSTATIC DISORDER 1 0.0002
513 ILL-DEFINED DISORDER 11 0.0002
514 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
515 GAIT INABILITY 6 0.0002
516 PRODUCT LEAKAGE 1 0.0002
517 ACUTE PULMONARY OEDEMA 1 0.0002
518 HYPERSENSITIVITY 33 0.0002
519 COLECTOMY 1 0.0002
520 SKIN TOXICITY 1 0.0002
521 MITRAL VALVE INCOMPETENCE 2 0.0002
522 GENERALISED ERYTHEMA 1 0.0002
523 INFLAMMATION 9 0.0002
524 CORONARY ARTERY BYPASS 1 0.0002
525 PRODUCT DOSE OMISSION 11 0.0002
526 SINUS HEADACHE 1 0.0002
527 NASOPHARYNGITIS 31 0.0002
528 CARDIAC PACEMAKER INSERTION 1 0.0002
529 URTICARIA 28 0.0002
530 GASTROENTERITIS VIRAL 3 0.0002
531 BRONCHITIS 12 0.0002
532 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
533 THINKING ABNORMAL 3 0.0002
534 TOOTH EXTRACTION 2 0.0002
535 SWELLING 15 0.0002
536 SWELLING OF EYELID 1 0.0002
537 UNEVALUABLE EVENT 12 0.0002
538 CYSTITIS 5 0.0002
539 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
540 LOWER LIMB FRACTURE 3 0.0002
541 GLAUCOMA 3 0.0002
542 HIP FRACTURE 5 0.0002
543 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
544 NODULE 2 0.0002
545 PRODUCT PREPARATION ISSUE 1 0.0002
546 SOMNAMBULISM 1 0.0002
547 IMPAIRED HEALING 5 0.0002
548 HYPOGAMMAGLOBULINAEMIA 1 0.0002
549 BEDRIDDEN 2 0.0002
550 TOOTH INFECTION 2 0.0002
551 CORONAVIRUS INFECTION 1 0.0002
552 VIRAL INFECTION 5 0.0002
553 LIP SWELLING 5 0.0001
554 FUNGAL INFECTION 5 0.0001
555 BREAST MASS 1 0.0001
556 METASTASES TO LYMPH NODES 1 0.0001
557 POSTOPERATIVE WOUND INFECTION 1 0.0001
558 ULCER HAEMORRHAGE 1 0.0001
559 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
560 RIB FRACTURE 3 0.0001
561 RESPIRATION ABNORMAL 1 0.0001
562 ACNE 11 0.0001
563 FORMICATION 1 0.0001
564 FEELING COLD 4 0.0001
565 APHONIA 2 0.0001
566 MASS 2 0.0001
567 DIALYSIS 2 0.0001
568 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
569 METASTASIS 1 0.0001
570 PRODUCT SUPPLY ISSUE 1 0.0001
571 HERPES ZOSTER 8 0.0001
572 PERIPHERAL SWELLING 21 0.0001
573 CARDIOMYOPATHY 2 0.0001
574 BLOOD POTASSIUM DECREASED 4 0.0001
575 THERAPEUTIC RESPONSE DECREASED 8 0.0001
576 AORTIC ANEURYSM 1 0.0001
577 APHTHOUS ULCER 1 0.0001
578 HYPOALBUMINAEMIA 1 0.0001
579 PELVIC FRACTURE 1 0.0001
580 ACUTE MYELOID LEUKAEMIA 2 0.0001
581 BASAL CELL CARCINOMA 2 0.0001
582 NASAL DISCOMFORT 1 0.0001
583 PNEUMOTHORAX 2 0.0001
584 RENAL CYST 1 0.0001
585 PRODUCT STORAGE ERROR 11 0.0001
586 GINGIVAL PAIN 1 0.0001
587 INFLUENZA 14 0.0001
588 BLOOD DISORDER 1 0.0001
589 STENT PLACEMENT 1 0.0001
590 FRUSTRATION TOLERANCE DECREASED 1 0.0001
591 LUNG DISORDER 6 0.0001
592 MULTIPLE FRACTURES 2 0.0001
593 HYPERAESTHESIA 1 0.0001
594 EYE IRRITATION 7 0.0001
595 SPINAL COMPRESSION FRACTURE 1 0.0001
596 DEATH 104 0.0001
597 CANDIDA INFECTION 2 0.0001
598 INFECTION 17 0.0001
599 FACIAL PARALYSIS 1 0.0001
600 SCAR 2 0.0001
601 BLOOD MAGNESIUM DECREASED 1 0.0001
602 HAEMORRHAGE 12 0.0001
603 URINE OUTPUT DECREASED 1 0.0001
604 JOINT STIFFNESS 3 0.0001
605 NAIL DISORDER 1 0.0001
606 IMMUNOSUPPRESSION 1 0.0001
607 SLEEP DISORDER 8 0.0001
608 LUNG INFILTRATION 1 0.0001
609 DRUG ERUPTION 2 0.0001
610 FACIAL PAIN 1 0.0001
611 LEUKOCYTOSIS 2 0.0001
612 TOOTHACHE 2 0.0001
613 PATHOGEN RESISTANCE 1 0.0001
614 PNEUMONIA BACTERIAL 1 0.0001
615 BRAIN NEOPLASM 1 0.0001
616 NERVE COMPRESSION 1 0.0001
617 IRON DEFICIENCY ANAEMIA 1 0.0001
618 DIVERTICULITIS 3 0.0001
619 MENTAL STATUS CHANGES 3 0.0001
620 DEMENTIA 3 0.0001
621 ERYTHEMA MULTIFORME 1 0.0001
622 MIDDLE INSOMNIA 2 0.0001
623 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
624 PHOTOPHOBIA 2 0.0001
625 ABORTION INDUCED 1 0.0001
626 SPUTUM DISCOLOURED 1 0.0001
627 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
628 POST PROCEDURAL COMPLICATION 2 0.0001
629 ACUTE RESPIRATORY FAILURE 2 0.0001
630 PANCREATIC CARCINOMA 3 0.0001
631 DRUG INTOLERANCE 10 0.0001
632 ATELECTASIS 1 0.0001
633 DIZZINESS POSTURAL 1 0.0001
634 COELIAC DISEASE 1 0.0001
635 ALOPECIA 20 0.0001
636 HOSPICE CARE 1 0.0001
637 LIGAMENT SPRAIN 1 0.0001
638 MALAISE 44 0.0001
639 RESPIRATORY DISORDER 3 0.0001
640 BRAIN INJURY 1 0.0001
641 CARDIAC FAILURE CONGESTIVE 8 0.0001
642 THROMBOSIS 8 0.0001
643 LACRIMATION INCREASED 3 0.0001
644 EMPHYSEMA 1 0.0001
645 HYPOTHERMIA 1 0.0001
646 TASTE DISORDER 2 0.0001
647 DRY THROAT 1 0.0001
648 FLUID RETENTION 5 0.0001
649 HOSPITALISATION 15 0.0001
650 INITIAL INSOMNIA 1 0.0001
651 HELICOBACTER INFECTION 1 0.0001
652 SWOLLEN TONGUE 3 0.0001
653 PETECHIAE 1 0.0001
654 PRODUCT ODOUR ABNORMAL 1 0.0001
655 TRANSFUSION 1 0.0001
656 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
657 FULL BLOOD COUNT ABNORMAL 1 0.0001
658 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
659 BREAST PAIN 1 0.0001
660 IMPAIRED WORK ABILITY 2 0.0001
661 BODY HEIGHT DECREASED 1 0.0001
662 CONTUSION 9 0.0001
663 POOR QUALITY SLEEP 2 0.0001
664 DRUG EFFECT DECREASED 5 0.0001
665 SKIN LACERATION 1 0.0001
666 PRODUCT PRESCRIBING ISSUE 2 0.0001
667 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
668 OESOPHAGITIS 1 0.0001
669 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
670 MUSCULOSKELETAL STIFFNESS 8 0.0001
671 EYE DISORDER 3 0.0001
672 STEVENS-JOHNSON SYNDROME 2 0.0001
673 IMPAIRED DRIVING ABILITY 1 0.0001
674 ILLNESS 9 0.0001
675 NEOPLASM 1 0.0001
676 MUSCLE TWITCHING 2 0.0001
677 PERICARDIAL EFFUSION 2 0.0001
678 ELECTROLYTE IMBALANCE 1 0.0001
679 POST PROCEDURAL HAEMORRHAGE 1 0.0001
680 RENAL DISORDER 4 0.0001
681 VASCULITIS 1 0.0001
682 CARDIAC DISORDER 8 0.0001
683 COVID-19 PNEUMONIA 1 0.0001
684 PAIN 52 0.0001
685 OCULAR HYPERAEMIA 4 0.0001
686 FALL 28 0.0001
687 ACCIDENT 1 0.0001
688 DRUG EFFECT INCOMPLETE 3 0.0001
689 BURSITIS 1 0.0001
690 FEELING HOT 5 0.0001
691 DYSURIA 3 0.0001
692 ENCEPHALOPATHY 2 0.0001
693 HYPERCALCAEMIA 1 0.0001
694 DYSGEUSIA 6 0.0001
695 EYE SWELLING 3 0.0001
696 CYST 1 0.0001
697 MEMORY IMPAIRMENT 11 0.0001
698 SECRETION DISCHARGE 1 0.0001
699 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
700 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
701 HIATUS HERNIA 1 0.0001
702 SWELLING FACE 5 0.0001
703 CEREBROVASCULAR ACCIDENT 13 0.0001
704 NERVOUSNESS 4 0.0001
705 PARAESTHESIA 12 0.0001
706 ADVERSE REACTION 1 0.0001
707 EAR INFECTION 2 0.0001
708 PRODUCT USE ISSUE 14 0.0001
709 EXTRA DOSE ADMINISTERED 3 0.0001
710 SINUS CONGESTION 1 0.0001
711 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
712 OEDEMA 4 0.0001
713 LIMB INJURY 2 0.0001
714 DRUG INEFFECTIVE 97 0.0001
715 GINGIVAL BLEEDING 1 0.0001
716 ABNORMAL DREAMS 2 0.0001
717 ORAL DISCOMFORT 1 0.0001
718 COUGH 20 0.0001
719 BLOOD TEST ABNORMAL 1 0.0001
720 LYMPHOPENIA 1 0.0001
721 FATIGUE 55 0.0001
722 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
723 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
724 HYPERSOMNIA 2 0.0001
725 PARAESTHESIA ORAL 1 0.0001
726 FLUID OVERLOAD 1 0.0001
727 DYSSTASIA 2 0.0001
728 BONE PAIN 4 0.0001
729 PAIN IN EXTREMITY 20 0.0001
730 ACUTE MYOCARDIAL INFARCTION 2 0.0001
731 CATARACT 4 0.0001
732 ASTHENIA 25 0.0001
733 PREMATURE BABY 2 0.0001
734 HYPOAESTHESIA ORAL 1 0.0001
735 DISCOMFORT 4 0.0001
736 MUSCLE SPASMS 12 0.0001
737 PHARYNGEAL OEDEMA 1 0.0001
738 DEVICE RELATED INFECTION 1 0.0001
739 MYALGIA 11 0.0001
740 LUNG INFECTION 1 0.0001
741 BLOOD CHOLESTEROL INCREASED 3 0.0001
742 HEAD INJURY 2 0.0001
743 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
744 DISEASE RECURRENCE 3 0.0001
745 ULCER 1 0.0001
746 PRODUCTIVE COUGH 3 0.0001
747 SCIATICA 1 0.0001
748 ABSCESS 1 0.0001
749 CONFUSIONAL STATE 10 0.0001
750 BACK DISORDER 1 0.0001
751 INFLUENZA LIKE ILLNESS 5 0.0001
752 PHOTOSENSITIVITY REACTION 1 0.0001
753 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
754 URINARY RETENTION 2 0.0001
755 CHILLS 7 0.0001
756 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
757 PNEUMONIA 19 0.0001
758 URINARY TRACT INFECTION 10 0.0001
759 SINUSITIS 6 0.0001
760 FEELING ABNORMAL 14 0.0001
761 BALANCE DISORDER 5 0.0001
762 DEPRESSED MOOD 3 0.0001
763 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
764 HEAD DISCOMFORT 1 0.0001
765 GOUT 1 0.0001
766 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
767 RESTLESSNESS 2 0.0001
768 ADVERSE EVENT 5 0.0001
769 BLOOD GLUCOSE ABNORMAL 1 0.0001
770 HYPOAESTHESIA 8 0.0001
771 OXYGEN SATURATION DECREASED 3 0.0001
772 HEPATIC CIRRHOSIS 1 0.0001
773 FRACTURE 1 0.0001
774 COLITIS 2 0.0001
775 FOOT FRACTURE 1 0.0001
776 DYSPHAGIA 5 0.0001
777 BLOOD URINE PRESENT 1 0.0001
778 GASTRIC ULCER 1 0.0001
779 PULMONARY EMBOLISM 5 0.0001
780 NEUROPATHY PERIPHERAL 5 0.0001
781 MUSCULOSKELETAL DISORDER 1 0.0001
782 FEELING JITTERY 1 0.0001
783 INCREASED APPETITE 1 0.0001
784 BLOOD PRESSURE INCREASED 8 0.0001
785 GAIT DISTURBANCE 10 0.0001
786 PULMONARY FIBROSIS 1 0.0001
787 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
788 HERNIA 1 0.0001
789 EAR PAIN 1 0.0001
790 ATRIAL FIBRILLATION 5 0.0001
791 COVID-19 9 0.0001
792 HAEMORRHOIDS 1 0.0001
793 CHOKING 1 0.0001
794 NASAL CONGESTION 3 0.0001
795 BLADDER CANCER 3 0.0001
796 ARTHRITIS 4 0.0001
797 HAEMATOCRIT DECREASED 1 0.0001
798 PRESCRIBED UNDERDOSE 1 0.0001
799 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
800 ABORTION SPONTANEOUS 2 0.0000
801 SPINAL FRACTURE 1 0.0000
802 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
803 FULL BLOOD COUNT DECREASED 1 0.0000
804 VERTIGO 3 0.0000
805 BONE MARROW FAILURE 1 0.0000
806 BLINDNESS 2 0.0000
807 DIZZINESS 24 0.0000
808 PULMONARY HYPERTENSION 1 0.0000
809 HEADACHE 30 0.0000
810 ROAD TRAFFIC ACCIDENT 2 0.0000
811 MOUTH ULCERATION 1 0.0000
812 OSTEOARTHRITIS 2 0.0000
813 EATING DISORDER 1 0.0000
814 IRRITABLE BOWEL SYNDROME 1 0.0000
815 LIVER FUNCTION TEST INCREASED 1 0.0000
816 HYPERHIDROSIS 6 0.0000
817 HYPOACUSIS 2 0.0000
818 RHINORRHOEA 3 0.0000
819 FAECES DISCOLOURED 1 0.0000
820 SEPTIC SHOCK 2 0.0000
821 MENTAL DISORDER 2 0.0000
822 MYOCARDIAL INFARCTION 8 0.0000
823 INSOMNIA 12 0.0000
824 TOOTH DISORDER 1 0.0000
825 RASH MACULO-PAPULAR 1 0.0000
826 HYPOTENSION 9 0.0000
827 SEPSIS 5 0.0000
828 SNEEZING 1 0.0000
829 THROAT IRRITATION 2 0.0000
830 PANCREATITIS ACUTE 1 0.0000
831 HEART RATE IRREGULAR 1 0.0000
832 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
833 NEPHROLITHIASIS 2 0.0000
834 TINNITUS 2 0.0000
835 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
836 BACK PAIN 10 0.0000
837 COGNITIVE DISORDER 2 0.0000
838 PRODUCT PRESCRIBING ERROR 1 0.0000
839 MIGRAINE 4 0.0000
840 ABDOMINAL DISCOMFORT 7 0.0000
841 BLOOD PRESSURE FLUCTUATION 1 0.0000
842 NEURALGIA 1 0.0000
843 DYSPNOEA 23 0.0000
844 ABASIA 1 0.0000
845 EPISTAXIS 3 0.0000
846 HAEMATEMESIS 1 0.0000
847 HYPOPHAGIA 1 0.0000
848 HAEMOGLOBIN DECREASED 4 0.0000
849 ERECTILE DYSFUNCTION 1 0.0000
850 ANAPHYLACTIC SHOCK 1 0.0000
851 DECREASED APPETITE 9 0.0000
852 HAEMATOMA 1 0.0000
853 RESPIRATORY TRACT INFECTION 1 0.0000
854 DEAFNESS 1 0.0000
855 MUSCULOSKELETAL PAIN 2 0.0000
856 DERMATITIS ATOPIC 2 0.0000
857 PLATELET COUNT DECREASED 4 0.0000
858 PRODUCT DOSE OMISSION ISSUE 11 0.0000
859 BLOOD BILIRUBIN INCREASED 1 0.0000
860 THROAT TIGHTNESS 1 0.0000
861 PRODUCT QUALITY ISSUE 5 0.0000
862 NAUSEA 29 0.0000
863 RESPIRATORY DISTRESS 1 0.0000
864 MEDICATION ERROR 2 0.0000
865 HAEMOPTYSIS 1 0.0000
866 WEIGHT DECREASED 10 0.0000
867 PANCYTOPENIA 2 0.0000
868 EYE PAIN 2 0.0000
869 DEPRESSION 8 0.0000
870 RED BLOOD CELL COUNT DECREASED 1 0.0000
871 LETHARGY 2 0.0000
872 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
873 PYREXIA 12 0.0000
874 DYSPHONIA 2 0.0000
875 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
876 ASCITES 1 0.0000
877 LABORATORY TEST ABNORMAL 1 0.0000
878 TACHYCARDIA 3 0.0000
879 OESOPHAGEAL CARCINOMA 1 0.0000
880 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
881 GASTROINTESTINAL DISORDER 3 0.0000
882 ADVERSE DRUG REACTION 3 0.0000
883 IRRITABILITY 2 0.0000
884 HEPATIC FAILURE 1 0.0000
885 JOINT SWELLING 4 0.0000
886 NO ADVERSE EVENT 6 0.0000
887 APHASIA 1 0.0000
888 CORONARY ARTERY DISEASE 1 0.0000
889 STOMATITIS 2 0.0000
890 PLEURAL EFFUSION 2 0.0000
891 DIARRHOEA 21 0.0000
892 EMOTIONAL DISORDER 1 0.0000
893 OROPHARYNGEAL PAIN 3 0.0000
894 LIMB DISCOMFORT 1 0.0000
895 NERVOUS SYSTEM DISORDER 1 0.0000
896 WEIGHT INCREASED 7 0.0000
897 DEEP VEIN THROMBOSIS 2 0.0000
898 AMNESIA 2 0.0000
899 CHOLELITHIASIS 1 0.0000
900 RENAL FAILURE 4 0.0000
901 EYE PRURITUS 1 0.0000
902 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
903 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
904 GASTRIC DISORDER 1 0.0000
905 NEOPLASM PROGRESSION 1 0.0000
906 HYPERKALAEMIA 1 0.0000
907 INJURY 2 0.0000
908 HYPERTENSION 6 0.0000
909 CEREBRAL HAEMORRHAGE 1 0.0000
910 MOBILITY DECREASED 2 0.0000
911 VOMITING 13 0.0000
912 C-REACTIVE PROTEIN INCREASED 1 0.0000
913 RESPIRATORY FAILURE 2 0.0000
914 UNDERDOSE 2 0.0000
915 ACCIDENTAL OVERDOSE 1 0.0000
916 CHEST PAIN 5 0.0000
917 DYSARTHRIA 1 0.0000
918 ASTHMA 3 0.0000
919 HOT FLUSH 2 0.0000
920 INTESTINAL OBSTRUCTION 1 0.0000
921 MUSCULAR WEAKNESS 3 0.0000
922 DIABETES MELLITUS 2 0.0000
923 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
924 ABDOMINAL PAIN 6 0.0000
925 PLASMA CELL MYELOMA 1 0.0000
926 PALPITATIONS 3 0.0000
927 DISORIENTATION 1 0.0000
928 INJECTION SITE HAEMORRHAGE 2 0.0000
929 CARDIAC FAILURE 2 0.0000
930 SOMNOLENCE 5 0.0000
931 OEDEMA PERIPHERAL 3 0.0000
932 NEUTROPHIL COUNT DECREASED 1 0.0000
933 CARDIAC ARREST 2 0.0000
934 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
935 VISUAL IMPAIRMENT 3 0.0000
936 ARTHRALGIA 10 0.0000
937 RHABDOMYOLYSIS 1 0.0000
938 CARDIO-RESPIRATORY ARREST 1 0.0000
939 WITHDRAWAL SYNDROME 1 0.0000
940 ANGIOEDEMA 1 0.0000
941 PULMONARY OEDEMA 1 0.0000
942 NEUTROPENIA 3 0.0000
943 VISION BLURRED 3 0.0000
944 HYPOKALAEMIA 1 0.0000
945 BLOOD GLUCOSE INCREASED 4 0.0000
946 COMA 1 0.0000
947 RENAL CANCER 1 0.0000
948 ANAEMIA 4 0.0000
949 BLOOD GLUCOSE DECREASED 1 0.0000
950 DRY EYE 1 0.0000
951 ABDOMINAL DISTENSION 2 0.0000
952 PANCREATITIS 1 0.0000
953 BRADYCARDIA 1 0.0000
954 DISTURBANCE IN ATTENTION 1 0.0000
955 CONSTIPATION 4 0.0000
956 HAEMATOCHEZIA 1 0.0000
957 ANAPHYLACTIC REACTION 1 0.0000
958 TREMOR 3 0.0000
959 ARTHROPATHY 1 0.0000
960 THROMBOCYTOPENIA 2 0.0000
961 HYPONATRAEMIA 1 0.0000
962 SEIZURE 2 0.0000
963 WHEEZING 1 0.0000
964 SUICIDE ATTEMPT 1 0.0000
965 INTENTIONAL OVERDOSE 1 0.0000
966 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
967 DEVICE MALFUNCTION 1 0.0000
968 ANXIETY 4 0.0000
969 HALLUCINATION 1 0.0000
970 DRUG INTERACTION 2 0.0000
971 INJECTION SITE BRUISING 1 0.0000
972 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
973 TREATMENT FAILURE 1 0.0000
974 HEART RATE INCREASED 1 0.0000
975 SYNCOPE 1 0.0000
976 FLUSHING 1 0.0000
977 CHEST DISCOMFORT 1 0.0000
978 PSORIASIS 1 0.0000
979 DEHYDRATION 1 0.0000
980 ACUTE KIDNEY INJURY 1 0.0000
981 ABDOMINAL PAIN UPPER 1 0.0000
982 OVERDOSE 1 0.0000